U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.716T>A (p.Leu239Gln) AND not specified

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Aug 15, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000779824.10

Allele description [Variation Report for NM_000465.4(BARD1):c.716T>A (p.Leu239Gln)]

NM_000465.4(BARD1):c.716T>A (p.Leu239Gln)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.716T>A (p.Leu239Gln)
Other names:
p.L239Q:CTG>CAG
HGVS:
  • NC_000002.12:g.214781158A>T
  • NG_012047.3:g.33554T>A
  • NM_000465.4:c.716T>AMANE SELECT
  • NM_001282543.2:c.659T>A
  • NM_001282545.2:c.215+15903T>A
  • NM_001282548.2:c.158+28254T>A
  • NM_001282549.2:c.364+11139T>A
  • NP_000456.2:p.Leu239Gln
  • NP_001269472.1:p.Leu220Gln
  • LRG_297t1:c.716T>A
  • LRG_297:g.33554T>A
  • LRG_297p1:p.Leu239Gln
  • NC_000002.11:g.215645882A>T
  • NG_012047.2:g.33547T>A
  • NM_000465.2:c.716T>A
  • NM_000465.3:c.716T>A
  • NR_104212.2:n.681T>A
  • NR_104215.2:n.624T>A
  • p.L239Q
Protein change:
L220Q
Links:
dbSNP: rs200359745
NCBI 1000 Genomes Browser:
rs200359745
Molecular consequence:
  • NM_001282545.2:c.215+15903T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+28254T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.364+11139T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000465.4:c.716T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.659T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.681T>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.624T>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

  • Felis catus
    Felis catus
    Felis catus trio and duo raw sequencing reads
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000916646Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Oct 10, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link,

SCV002071335Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Oct 25, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002760251Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Aug 15, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Multigene testing of moderate-risk genes: be mindful of the missense.

Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, et al.

J Med Genet. 2016 Jun;53(6):366-76. doi: 10.1136/jmedgenet-2015-103398. Epub 2016 Jan 19.

PubMed [citation]
PMID:
26787654
PMCID:
PMC4893078

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman AR, Winer EP, Garber JE.

J Clin Oncol. 2016 May 1;34(13):1460-8. doi: 10.1200/JCO.2015.65.0747. Epub 2016 Mar 14.

PubMed [citation]
PMID:
26976419
PMCID:
PMC4872307
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000916646.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Variant summary: BARD1 c.716T>A (p.Leu239Gln) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 217412 control chromosomes, predominantly at a frequency of 0.00017 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is somewhat lower than the expected maximum for a pathogenic variant in BARD1 causing Hereditary Breast and Ovarian Cancer (0.00017 vs 0.00025), allowing no clear conclusions about variant significance. c.716T>A has been reported in the literature in individuals with a personal or family history of breast and/or ovarian cancer (e.g. Tung_2016, Tsaousis_2019, Adamovich_2019) and other tumor phenotypes (Adamovich_2019); however without strong evidence for causality. These reports therefore do not provide unequivocal conclusions about association of the variant with Hereditary Breast and Ovarian Cancer. One publication reported experimental evidence demonstrating that the variant protein is fully functional in homology-directed DNA repair (HDR) (Adamovich_2019). Ten other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation: nine laboratories cited the variant as uncertain significance, while one cited the variant as likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV002071335.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV002760251.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024